• 1 June 2018

    May’s top news stories

    Abivax unveiled new data that may suggest its clinical candidate ABX464 could be a safe, functional cure for human immunodeficiency virus (HIV), as well as a method to treat inflammatory...

  • 4 May 2018

    April’s top news stories

    The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended three medications for approval during its April meeting, and Drug development company Proniras has entered...

  • 30 April 2018

    EMA recommends three medicines for approval

    The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended three medications for approval during its April meeting.

  • 3 April 2018

    Sanofi seeks EMA approval for asthma drug Dupixent

    The European Medicines Agency (EMA) has accepted Sanofi’s application to review its drug Dupixent (dupilumab) as an add-on maintenance treatment in patients aged 12 years and older with inadequately controlled...